Exelixis, Inc. (NASDAQ:EXEL) announced that data from clinical trials of cabozantinib and cobimetinib will be the subject of three presentations at the European Cancer …
Exelixis, Inc. (NASDAQ:EXEL) announced the U.
Exelixis, Inc. (NASDAQ:EXEL) reported financial results for the second quarter of 2015 and provided an update on progress toward delivering upon its key 2015 …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares increased 5.55% in pre-market trading to $585.
Exelixis, Inc. (NASDAQ:EXEL) announced the pricing of its underwritten public offering of 25,000,000 shares of newly issued common stock at a price to the …
Apple Inc. (NASDAQ:AAPL) shares slipped -6% in pre-market trading to $122.
Exelixis, Inc. (NASDAQ:EXEL) announced that it plans to offer, subject to market and other conditions, 20,000,000 shares of its common stock in an underwritten …
GoPro Inc (NASDAQ:GPRO) shares are up 2.40% in pre-market trading to $58.
Exelixis, Inc. (NASDAQ:EXEL) announced positive top-line results from the primary analysis of METEOR, the phase 3 pivotal trial comparing cabozantinib to everolimus in …
Exelixis, Inc. (NASDAQ:EXEL) announced the appointment of Christopher J.
